Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Chemistry and Laboratory Medicine|October 31, 2024
Evidence for stability of cardiac troponin T concentrations measured with a high sensitivity TnT test in serum and lithium heparin plasma after six-year storage at -80 °C and multiple freeze-thaw cyclesLinda M Henricks, Fred P H T M Romijn, Christa M Cobbaert
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Letter regarding Zhao et al. entitled " DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia"Maarten J Deenen, Linda M Henricks, Gabe S Sonke, et al.
Cancer Treatment Reviews|November 9, 2015
The use of combinations of monoclonal antibodies in clinical oncologyLinda M Henricks, Jan H M Schellens, Alwin D R Huitema, et al.
Clinical Pharmacology and Therapeutics|October 6, 2020
Individualized Dosing of Fluoropyrimidine-Based Chemotherapy to Prevent Severe Fluoropyrimidine-Related Toxicity: What Are the Options?Jonathan E Knikman, Hans Gelderblom, Jos H Beijnen, et al.
Transfusion Medicine (Oxford, England)|October 18, 2022
Acute haemolytic transfusion reaction after transfusion of fresh frozen plasma in a neonate-Preventable by using solvent/detergent-treated pooled plasma?Linda M Henricks, Elise J Huisman, Enrico Lopriore, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 15, 2016
Development and validation of a rapid and sensitive UPLC-MS/MS method for determination of uracil and dihydrouracil in human plasmaBart A W Jacobs, Hilde Rosing, Niels de Vries, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2015
Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime timeCarin A T C Lunenburg, Linda M Henricks, Henk-Jan Guchelaar, et al.
Pharmacogenomics|August 13, 2015
Translating DPYD genotype into DPD phenotype: using the DPYD gene activity scoreLinda M Henricks, Carin A T C Lunenburg, Didier Meulendijks, et al.
International Journal of Cancer|November 29, 2018
Effectiveness and safety of reduced-dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysisLinda M Henricks, Lisanne N van Merendonk, Didier Meulendijks, et al.
International Journal of Cancer|January 26, 2016
Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicityDidier Meulendijks, Linda M Henricks, Ursula Amstutz, et al.
Pageof 3